Status:
RECRUITING
Phage Safety Retrospective Cohort Study
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Bone and Joint Infection
Prosthetic Joint Infection
Eligibility:
All Genders
Brief Summary
The aim of this study is to determine the imputability of adverse events in patients who have had phage therapy for the treatment of their bone or joint or implant infection, in order to find out whet...
Eligibility Criteria
Inclusion
- patients having had a bone or joint or implant infection treated by phagotherapy and having had an adverse event
Exclusion
- \-
Key Trial Info
Start Date :
February 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04724603
Start Date
February 1 2021
End Date
September 1 2026
Last Update
April 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Lyon, France, 69004